Faraday Future shares are trading lower after the company announced their entry into the embodied AI robotics market, facing significant competition and challenges in securing necessary funding, which has contributed to its stock price decline.

McKesson shares are trading higher after the company reported its fiscal 2026 third quarter financial results, showcasing strong performance in the healthcare sector.

FMC Corporation shares are trading lower after the company announced its exploration of strategic options, including a potential sale, alongside a significant revenue drop linked to its India business being classified as held for sale.

Omnicell shares are trading lower after the company reported a GAAP net loss of $2 million for Q4 2025, compared to a net income of $16 million in the same period last year, despite a 2% increase in quarterly revenues.

SelectQuote shares are trading lower after the company revised its fiscal 2026 guidance, citing two discrete partner-driven headwinds: a national carrier's decision to constrain additional Medicare Advantage policy volume and previously communicated PBM reimbursement changes.

Ocular Therapeutix shares are trading higher after the company announced that the SOL-1 Phase 3 trial results for its AXPAXLI treatment in wet AMD are on track for presentation at the 49th Macula Society Annual Meeting, with expectations of submitting an NDA upon positive outcomes.

Phibro Animal Health Corporation shares are trading higher after the company reported a 21% increase in net sales and a significant boost in net income for Q2, prompting an upward revision in fiscal year 2026 guidance.

SiTime shares are trading higher following the announcement of its acquisition of Renesas' timing business, expected to generate $300 million in revenue within 12 months post-close, supporting SiTime’s robust financial outlook.

Geospace Technologies shares are trading lower after the company reported a significant decline in Q1 revenue and posted a net loss, highlighting ongoing challenges in their operating environment.

Peloton Interactive shares are trading lower after the announcement that Chief Financial Officer Liz Coddington will be departing to join Palmetto as CFO, following her pivotal four-year tenure at Peloton.

Broadwind shares are trading lower after announcing a raw material supply issue affecting its Heavy Fabrications segment's manufacturing throughput, along with anticipated revenue impact from the sale of its Manitowoc facility reducing projected 2026 revenue.

Green Plains shares are trading higher after the company reported a significant improvement in Q4 financial results, including a net income of $11.9 million compared to a net loss the previous year, boosted by higher ethanol production margins and the benefit of 45Z production tax credits.

FibroBiologics shares are trading higher after the company announced the issuance of a Canadian patent for its novel fibroblast-based treatment for cachexia, strengthening its IP portfolio and advancing innovative therapies for chronic diseases.

Hims & Hers shares are trading higher after the company announced the expansion of its weight loss solutions by introducing a needle-free Compounded Semaglutide Pill, leveraging nearly a decade of infrastructure investment to make personalized care more accessible.

AIM ImmunoTech shares are trading higher after the company reported positive data from an ongoing Phase 2 study of Ampligen in combination with AstraZeneca's Imfinzi for pancreatic cancer treatment.

Canada Goose Holdings Inc. shares are trading lower after the company's recent financial report indicated a net loss for three quarters ending December 28, 2025. The increased selling, general, and administrative expenses, including a one-time bad-debt provision and costs associated with expansion, alongside a non-recurring foreign exchange gain from the previous fiscal year, impacted the financial performance, resulting in a decrease in profit margins.

Byrna Technologies shares are trading higher after the company reported record fiscal fourth quarter and full-year 2025 results, with full-year revenue up 38% year-over-year due to expanded production capacity and retail presence.

TransCode Therapeutics shares are trading higher after the company announced the submission of an IND Amendment for a Phase 2a clinical trial with TTX-MC138, expanding their innovative oncology efforts into colorectal cancer.

Profusa shares are trading lower after the company announced a 1-for-75 reverse stock split.

Teads shares are trading higher after the company announced a strategic partnership with Google TV to significantly expand its connected TV HomeScreen ad inventory globally.